DOCSLIB.ORG

Management of Pelvic Pain from Dysmenorrhea Or Endometriosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Management of Pelvic Pain from Dysmenorrhea Or Endometriosis J Am Board Fam Pract: first published as 10.3122/jabfm.17.suppl_1.S43 on 1 December 2004. Downloaded from Management of Pelvic Pain from Dysmenorrhea or Endometriosis Laeth Nasir, MBBS, and Edward T. Bope, MD Many women suffer from pelvic pain, and a great many visit their family doctor for diagnosis and treat- ment. Two common causes are primary dysmenorrhea and endometriosis. Primary dysmenorrhea is best treated by prostaglandin inhibition from nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclo- oxygenase-2 (COX-2)-specific inhibitors. Oral contraceptives can be added to improve pain control. Endometriosis can be treated with NSAIDs and COX-2-specific inhibitors as well but can also be treated with hormonal manipulation or surgery. Empiric treatment for endometriosis in selected patients is now accepted, making the disorder easier for family physicians to manage. (J Am Board Fam Pract 2004;17:S43–7.) Pelvic pain is one of the most common problems pelvic pain is that which has lasted greater than 6 affecting women of reproductive age. The pain may months and occurs not solely with menses. vary from mildly irritating to incapacitating. Dys- menorrhea and endometriosis are the two most Prevalence common causes. Nonsteroidal anti-inflammatory A number of studies have estimated the prevalence drugs (NSAIDs) and cyclo-oxygenase-2 (COX-2)- of chronic pelvic pain to be similar to that reported specific inhibitors are the mainstays of therapy for for migraine, low back pain, and asthma.1,2 Dys- both disorders. Hormonal manipulation may also menorrhea and endometriosis are the two most copyright. be used in treatment. Surgical and alternative treat- common causes of pelvic pain. Primary dysmenor- ments are also discussed. rhea is a very common gynecologic problem in menstruating women. Reported prevalence rates Definitions are as high as 90%; 1 in 13 sufferers are incapaci- In the broadest sense, pelvic pain is considered any tated for 1 to 3 days per month, impacting school visceral pain presenting below the umbilicus. This and work attendance. Primary dysmenorrhea usu- article focuses on the two most common causes of ally presents during adolescence within 3 years of chronic pelvic pain: dysmenorrhea and endometri- menses. Most women who suffer from dysmenor- osis. Pain in the bowel and bladder are considered rhea do not seek medical care. http://www.jabfm.org/ to be outside the pelvis, although the astute clini- Endometriosis is seen in 5 to 10% of women in cian also takes into account the importance of these the general population and is thought to be more contiguous organs as causes of pain. Acute pelvic common in the mature woman, but it can also pain is defined as recent in onset, whereas chronic occur in adolescents and has been reported in girls as young as 10.5 years of age.3 The peak incidence is between the ages of 25 and 30 years. on 26 September 2021 by guest. Protected From the Department of Family Medicine, University of Nebraska at Omaha (LN), and Family Practice Residency Program, Riverside Methodist Hospital, Columbus, OH Management of Pelvic Pain (ETB). Address correspondence to: Edward T. Bope, MD, Dysmenorrhea ABFP, Riverside Family Practice Residency Program, Riv- erside Methodist Hospital, 697 Thomas Lane, Columbus, Affected women experience sharp, intermittent OH 43214 (e-mail: [email protected]). spasms associated with their menstrual cycle. It is The Family Practice Pain Education Project (FP-PEP) acknowledges an unrestricted educational grant from Pfizer usually centered in the suprapubic area but may to Cardinal Health to produce educational materials for radiate to the back of the legs or the lower back. primary care doctors about pain management. The informa- tion provided here is the opinions and research of the family Systemic symptoms of nausea, vomiting, diarrhea, physicians who served on FP-PEP. fatigue, fever, headache, or lightheadedness are This work was presented in part at the 2003 American Academy of Family Physicians (AAFP) Scientific Sympo- fairly common. The pelvic pain of dysmenorrhea sium. has been demonstrated to be mediated through the http://www.jabfp.org Managing Pelvic Pain S43 J Am Board Fam Pract: first published as 10.3122/jabfm.17.suppl_1.S43 on 1 December 2004. Downloaded from copyright. http://www.jabfm.org/ Figure 1. Primary dysmenorrhea treatment algorithm. action of prostaglandin factor 2x and is ischemic in tions are started 1 to 2 days before menses and nature; therefore, prostaglandin inhibition nearly continued for 2 days after menses starts. This first- always diminishes or resolves the pain. Numerous step treatment is effective in 80% of patients. For on 26 September 2021 by guest. Protected studies have documented the efficacy of standard those who fail to respond, oral contraceptive pills NSAIDs and COX-2-specific inhibitors acting or medroxyprogesterone can be added to achieve through prostaglandin synthetase inhibition to control. These medicines are effective in 90% of control dysmenorrhea (SORT A*).4 These medica- patients (SORT C).5 Figure 1 presents an algo- rithm for the management of primary dysmenor- rhea. * Levels of evidence using SORT: (1) treatment of pain Some alternative treatments for primary dys- caused by primary dysmenorrhea with NSAIDs or COX-2- specific inhibitors ϭ A; (2) treatment of pain caused by menorrhea have been studied and have shown some primary dysmenorrhea with oral contraceptive pills ϭ C; success. Topical heat at 38.9°C used for 12 hours (3) treatment of endometriosis empirically ϭ B; and (4) treatment of endometriosis pain with NSAIDs or COX-2- per day has been found to be as beneficial as specific inhibitors ϭ C. ibuprofen.6 Four small studies of 126 patients S44 JABFP November–December 2004 Vol. 17 Supplement http://www.jabfp.org J Am Board Fam Pract: first published as 10.3122/jabfm.17.suppl_1.S43 on 1 December 2004. Downloaded from Table 1. Secondary Causes of Dysmenorrhea and copy to visually and pathologically make the diag- Chronic Pelvic Pain nosis, with the advantage that any endometriosis Endometriosis found can be surgically treated at the same time. In Adenomyosis one placebo-controlled, double-blind, randomized Endometrial polyps trial of women with stage I, II, or III endometriosis, Leiomyomata 40% had alleviation of pain at 6 months that Pelvic inflammatory disease could be attributed to surgical debridement.14 Pro- Pelvic organ prolapse gestin, danazol, or gonadotropin-releasing hor- Adhesions mone (GnRH) analogs are generally used post- Musculoskeletal disorders operatively for greater duration of pain relief Gastrointestinal disorders (Figure 2).15,16 Urologic disorders Ling17 showed empiric treatment to be effective A history of sexual abuse in low-risk patients, including women aged 18 to 45 years with regular menses, no previous diagnosis of endometriosis, no hormonal treatment in the prior showed transcutaneous electrical nerve stimulation 3 months, no evidence of gastrointestinal or urinary (TENS) to give moderate relief in 40% to 60% of disease, normal pelvic ultrasound, normal complete patients.7,8 Acupuncture, when studied in 43 pa- blood count, normal urinalysis, negative gonorrhea tients for 1 year, showed a 91% improvement in and chlamydia culture, negative human chorionic symptoms and a 41% decrease in analgesic use.9 gonadotropin, and failure of NSAIDs and doxy- Daily thiamine (100 mg) for 90 days in 556 patients cycline to improve pain symptoms (SORT B). Of yielded an 87% cure rate up to 2 months after patients treated empirically, 80% experienced sig- treatment10 and, in adolescents, daily intake of ma- nificant improvement, including patients without rine ⍀-3 fatty acids netted significant improve- detectable endometriosis at subsequent laparos- ment.11 Nitroglycerin patches improved pain copy. The empiric treatment group must be care- copyright. symptoms in one uncontrolled trial.12 These alter- fully screened to be certain there is no concomitant native treatments can be used alone or as adjuvants disease, such as infection or pregnancy. to standard therapy. Whether identified surgically or empirically, en- If a 3- to 4-month trial of anti-inflammatory, dometriosis is treated with one or more of the hormonal, or alternative treatments has been inef- following: traditional NSAIDs, COX-2-specific in- fective, secondary causes of dysmenorrhea and pel- hibitors (SORT C), oral contraceptive pills vic pain should be considered (Table 1). In one (OCPs), GnRH agonists, progestins, or danazol. study of 100 women who had inadequate pain relief Traditional NSAIDs or COX-2 inhibitors are used http://www.jabfm.org/ with NSAIDs and/or oral contraceptives, almost initially at maximal or nearly maximal dosage. 80% had endometriosis on laparoscopy.12 Only af- There is no evidence to support switching from one ter these secondary causes have been ruled out NSAID to another to improve response, although would invasive options such as uterosacral nerve the practice is frequent.18 OCPs are used next if ablation, presacral neurectomy, or nerve block pro- pain relief has not been achieved, and they may be cedures, be considered. A Cochrane review did not used alone or in combination with NSAIDs. Using find sufficient evidence to recommend nerve inter- the “long cycle” approach with oral contraceptive on 26 September 2021 by guest. Protected ruption procedures for the treatment of pelvic pain pills (3 months of pills before a week without pills) caused by dysmenorrhea.13 can reduce the number of menses, thus improving the quality of life.19 No evidence supports switch- Endometriosis ing from one OCP to another to improve response. Endometriosis typically presents with the triad of High-dose progestins improve endometriosis by pelvic pain, dyspareunia, and infertility. Any of deciduation followed by pseudonecrosis and atro- these 3 issues could motivate a woman to seek care; phy of lesions. Progestins suppress gonadotropin most often, pain is the compelling reason for the release and ovarian function; for example, 50 mg/ visit.
Load more

Recommended publications
  • Different Influences of Endometriosis and Pelvic Inflammatory Disease On
    International Journal of Environmental Research and Public Health Article Different Influences of Endometriosis and Pelvic Inflammatory Disease on the Occurrence of Ovarian Cancer Jing-Yang Huang 1,2,†, Shun-Fa Yang 1,2 , Pei-Ju Wu 1,3,†, Chun-Hao Wang 4,†, Chih-Hsin Tang 5,6,7 and Po-Hui Wang 1,2,3,8,* 1 Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan; [email protected] (J.-Y.H.); [email protected] (S.-F.Y.); [email protected] (P.-J.W.) 2 Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan 3 Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 402, Taiwan 4 Department of Medicine, National Taiwan University, Taipei 106, Taiwan; [email protected] 5 School of Medicine, China Medical University, Taichung 404, Taiwan; [email protected] 6 Chinese Medicine Research Center, China Medical University, Taichung 404, Taiwan 7 Department of Medical Laboratory Science and Biotechnology, College of Medical and Health Science, Asia University, Taichung 413, Taiwan 8 School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan * Correspondence: [email protected] † Equal contributions as first authors. Abstract: To compare the rate and risk of ovarian cancer in patients with endometriosis or pelvic inflammatory disease (PID). A nationwide population cohort research compared the risk of ovarian cancer in 135,236 age-matched comparison females, 114,726 PID patients, and 20,510 endometriosis patients out of 982,495 females between 1 January 2002 and 31 December 2014 and ended on the date Citation: Huang, J.-Y.; Yang, S.-F.; of confirmation of ovarian cancer, death, or 31 December 2014.
    [Show full text]
  • LNG-IUS) in Patients Affected by Menometrorrhagia, Dysmenorrhea and Adenomimyois: Clinical and Ultrasonographic Reports
    European Review for Medical and Pharmacological Sciences 2021; 25: 3432-3439 The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports F. COSTANZI, M.P. DE MARCO, C. COLOMBRINO, M. CIANCIA, F. TORCIA, I. RUSCITO, F. BELLATI, A. FREGA, G. COZZA, D. CASERTA Department of Surgical and Medical Sciences and Translational Medicine, Sant’Andrea University Hospital, Sapienza University of Rome, Rome, Italy Abstract. – OBJECTIVE: Adenomyosis is p=0.025; p=0.014). The blood loss decreased the consequence of the myometrial invasion significantly in both the cohorts (p<0.001) and by endometrial glands and stroma. Transvag- particularly in adenomyotic patients. Pain relief inal ultrasonography plays a decisive role in was observed in all the patients (p<0.001). the diagnosis and monitoring of this patholo- CONCLUSIONS: LNG-IUS can be considered gy. Our study aims to evaluate the efficacy of an effective treatment for managing symptoms LNG-IUS (Levonorgestrel Releasing Intrauter- and improving uterine morphology. ine System) as medical therapy. We analyzed both clinical symptoms and ultrasonograph- Key Words: ic aspects of menometrorrhagia and dysmen- Benign disease of uterus, Dysmenorrhea, Gyne- orrhea in patients with adenomyosis and the cologic imaging, Leiomyomas of the uterus/adeno- control group. myosis. PATIENTS AND METHODS: A prospective co- hort study was carried out on 28 patients suf- fering from symptomatic adenomyosis treat- ed with LNG-IUS. Adenomyosis was diagnosed Introduction through transvaginal ultrasonography by an ex- pert sonographer. A control group of 27 symp- Adenomyosis is a benign gynecological dis- tomatic patients (menorrhagia and dysmenor- ease with a large variety of clinical manifestation; rhea) without a transvaginal ultrasonograph- the most frequent include menorrhagia, metror- ic diagnosis of adenomyosis was treated in the rhagia, dysmenorrhea and chronic pelvic pain1.
    [Show full text]
  • Management of Uterine Prolapse: Is Hysterectomy Necessary?
    DOI: 10.1111/tog.12220 2016;18:17–23 Review The Obstetrician & Gynaecologist http://onlinetog.org Management of uterine prolapse: is hysterectomy necessary? a b b, Helen Jefferis MRCOG, Simon Robert Jackson MD FRCOG, Natalia Price MD MRCOG * aSubspeciality Trainee in Urogynaecology, Department of Urogynaecology, Women’s Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK bConsultant Urogynaecologist, Department of Urogynaecology, Women’s Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK *Correspondence: Natalia Price. Email: [email protected] Accepted on 1 June 2015 Key content Fertility preservation remains the one absolute indication for Management of uterine prolapse is currently heavily influenced by hysteropexy. Other potential advantages include stronger apical patient and surgeon preferences. support and reduced vaginal surgery. The traditional approach to uterine prolapse is vaginal Colpocleisis remains a valid option for a small cohort of patients. hysterectomy. However, this does not address the underlying Learning objectives deficiency in connective tissue pelvic floor support, and prolapse Options for the management of uterine prolapse. recurrence is common. How to help patients decide on a management plan. Uterine preservation surgery is increasing in popularity, both with surgeons and patients; there is currently little evidence to show Keywords: colpocleisis / hysteropexy / pelvic organ prolapse / superior outcome to hysterectomy. uterine preservation surgery / vaginal hysterectomy Please cite this paper as: Jefferis H, Jackson SR, Price N. Management of uterine prolapse: is hysterectomy necessary? The Obstetrician & Gynaecologist 2016;18: 17–23. DOI: 10.1111/tog.12220 Introduction significantly associated with regression of prolapse, leading the authors to suggest that the damage obesity causes to the When a woman presents with pelvic organ prolapse, the pelvic floor may be irreversible.
    [Show full text]
  • Pelvic Organ Prolapse
    Quality ID #429: Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy – National Quality Strategy Domain: Patient Safety – Meaningful Measure Area: Preventable Healthcare Harm 2019 COLLECTION TYPE: MEDICARE PART B CLAIMS MEASURE TYPE: Process – High Priority DESCRIPTION: Percentage of patients who are screened for uterine malignancy prior to vaginal closure or obliterative surgery for pelvic organ prolapse INSTRUCTIONS: This measure is to be submitted each time a prolapse organ repair surgery is performed during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. Measure Submission Type: Measure data may be submitted by individual MIPS eligible clinicians using Medicare Part B claims. The listed denominator criteria are used to identify the intended patient population. The numerator quality-data codes included in this specification are used to submit the quality actions allowed by the measure on the claim form(s). All measure- specific coding should be submitted on the claim(s) representing the denominator eligible encounter and selected numerator option. DENOMINATOR: All patients undergoing surgery for pelvic organ prolapse involving vaginal closure/obliterative procedure Denominator Criteria (Eligible Cases): All patients, regardless of age AND Patient procedure during
    [Show full text]
  • Histopathology Findings of the Pelvic Organ Prolapse
    Review Histopathology fndings of the pelvic organ prolapse FERNANDA M.A. CORPAS1, ANDRES ILLARRAMENDI2, FERNANDA NOZAR3, BENEDICTA CASERTA4 1 Asistente Clínica Ginecotocológica A CHPR, 2 Residente de Ginecología, Clínica Ginecotocológica A CHPR, 3 Profesora Adjunta Clínica Ginecotocológica A CHPR, 4 Jefa del servicio de Anatomía Patológica del CHPR, Presidenta de la Sociedad de Anatomía Patológica del Uruguay, Centro Hospitalario Pereira Rossell (Chpr), Montevideo, Uruguay Abstract: Pelvic organ prolapse is a benign condition, which is the result of a weakening of the different components that provide suspension to the pelvic foor. Surgical treatment, traditionally involve a vaginal hysterectomy, although over the last few decades the preservation of the uterus has become more popular. The objective of the paper is to analyze the characteristics of those patients diagnosed with pelvic organ prolapse, whose treatment involved a vaginal hysterectomy and its correlation to the histopathological characteristics. Retrospective, descriptive study. Data recovered from the medical history of patients that underwent surgical treatment for pelvic organ prolapse through vaginal hysterectomy, were analyzed in a 2 years period, in the CHPR, and compared to the pathology results of the uterus. At the level of the cervix, 58,2% presented changes related to the prolapse (acantosis, para and hyperqueratosis) and 43,6% chronic endocervicitis. Findings in the corpus of the uterus were 58,2% atrophy of the endometrium, 21% of endometrial polyps and 30.9% leiomiomas and 1 case of simple hyperplasia without cellular atypias. No malignant lesions were found. The pathology results of the uterus reveal the presence of anatomical changes related to the pelvic organ prolapse and in accordance to the age of the patient, as well as associated pathologies to a lesser extent.
    [Show full text]
  • Gynecological-DBQ
    INTERNAL VETERANS AFFAIRS USE GYNECOLOGICAL CONDITIONS DISABILITY BENEFITS QUESTIONNAIRE IMPORTANT - THE DEPARTMENT OF VETERANS AFFAIRS (VA) WILL NOT PAY OR REIMBURSE ANY EXPENSES OR COST INCURRED IN THE PROCESS OF COMPLETING AND/OR SUBMITTING THIS FORM. PLEASE READ THE PRIVACY ACT AND RESPONDENT BURDEN INFORMATION ON REVERSE BEFORE COMPLETING FORM. NAME OF PATIENT/VETERAN PATIENT/VETERAN'S SOCIAL SECURITY NUMBER NOTE TO PHYSICIAN - Your patient is applying to the U.S. Department of Veterans Affairs (VA) for disability benefits. VA will consider the information you provide on this questionnaire as part of their evaluation in processing the claim. VA reserves the right to confirm the authenticity of ALL DBQs completed by private health care providers. IS THIS DBQ BEING COMPLETED IN CONJUNCTION WITH A VA21-2507, C&P EXAMINATION REQUEST? YES NO If no, how was the examination completed (check all that apply)? In-person examination Records reviewed Other, please specify: Comments: ACCEPTABLE CLINICAL EVIDENCE (ACE) INDICATE METHOD USED TO OBTAIN MEDICAL INFORMATION TO COMPLETE THIS DOCUMENT: Review of available records (without in-person or video telehealth examination) using the Acceptable Clinical Evidence (ACE) process because the existing medical evidence provided sufficient information on which to prepare the DBQ and such an examination will likely provide no additional relevant evidence. Review of available records in conjunction with a telephone interview with the Veteran (without in-person or telehealth examination) using the ACE process because the existing medical evidence supplemented with a telephone interview provided sufficient information on which to prepare the DBQ and such an examination would likely provide no additional relevant evidence.
    [Show full text]
  • Gynecology Revised: 11/2013
    Emergency Medical Training Services Emergency Medical Technician – Paramedic Program Outlines Outline Topic: Gynecology Revised: 11/2013 21 questions on exam 8 from this outline • Menstruation - normal periodic discharge of blood, mucus, and cellular debris from uterus. The normal menstrual cycle lasts about 28 days. 25 to 60mL average flow. Flow lasts usually 4 to 6 days. Lining of the uterus is called endometrium. Onset of menses (menarche) begins around 12 years of age. Menopause starts at age 47 on average. But can range from 30 to 60 years of age. Estrogen stimulates endometrium to grow and increase in thickness. • Ovaries contain about 5 million cells to make oocytes (immature ova/eggs). At puberty 350,000 are present. In a lifetime the ovary will release 400 through menstruation • The release of the egg is termed ovulation. • The pituitary released FSH to stimulate the ovaries to produce estrogen. As a result of the estrogen builds up in blood stream just before ovulation the pituitary releases luteinizing hormone to initiate the release of eggs. • Up to seven days after ovulation (day 21) the uterus is ready to receive an embryo if fertilization has happened. • Recap: Day 14 ovulation. Up to day 21 fertilization window, day 22 thru 28 period if not pregnant. GYN emergencies are classified as: Non-traumatic • PID - infection entered the pelvis cavity. Most common causes are non-sterile exam equipment and if sexually transmitted is N. Gonorrhea and Chlamydia. Lower abdominal pain, hurts with sex, vaginal discharge and additional bleeding after period is over. Antibiotic therapy is needed. • Ovarian cyst - can be a bleeding/shock emergency.
    [Show full text]
  • Management of Primary Dysmenorrhea in Young Women with Frameless LNG-IUS
    Open Access Journal of Contraception Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Management of primary dysmenorrhea in young women with frameless LNG-IUS Dirk Wildemeersch1 Abstract: The objective of this paper is to discuss the potential advantages of intrauterine treat- Sohela Jandi2 ment with a frameless levonorgestrel (LNG)-releasing intrauterine system (IUS) in young women Ansgar Pett2 presenting with primary dysmenorrhea associated with heavy menstrual bleeding. The paper is Thomas Hasskamp3 based on clinical reports of 21 cases of primary and secondary dysmenorrhea treated with the frameless LNG-IUS. Three typical examples of young women between 16 and 20 years of age, 1Gynecological Outpatient Clinic and IUD Training Center, Ghent, who presented with moderate-to-severe primary dysmenorrhea associated with heavy menstrual Belgium; 2Gynecological Outpatient bleeding, are presented as examples. Following pelvic examination, including vaginal sonography, 3 Clinic, Berlin, Germany; GynMünster, a frameless LNG-IUS, releasing 20 µg of LNG/day, was inserted. The three patients developed Münster, Germany amenorrhea, or scanty menstrual bleeding, and absence of pain complaints within a few months. We conclude that continuous, intrauterine progestogen delivery could be a treatment of choice of this inconvenient condition. In addition, the good experiences with the frameless LNG-IUS in other studies suggests that the frameless design may be preferred over a framed LNG-IUS, as the absence of a frame, resulting in optimal tolerance, is particularly advantageous in these women. Keywords: heavy menstrual bleeding, contraception, FibroPlant, intrauterine system Video abstract Introduction In an epidemiologic study of an adolescent population, Klein and Litt reported a prevalence of dysmenorrhea of 59.7%.1 Of patients reporting pain, 12% described it as severe, 37% as moderate, and 49% as mild.
    [Show full text]
  • Epidemiology of Menstrual Disorders in Developing Countries: a Systematic Review
    BJOG: an International Journal of Obstetrics and Gynaecology DOI: 10.1046/j.1471-0528.2003.00012.x January 2004, Vol. 111, pp. 6–16 REVIEW Epidemiology of menstrual disorders in developing countries: a systematic review Introduction Information on the prevalence of menstrual complaints in the past three months was obtained in seven countries In developing countries, priority setting in the health (Table 1). These data permit cross national comparisons sector traditionally focuses on the principal causes of mor- in so far as similar questions with a similar time reference tality. More recently, the Global Burden of Disease approach were asked. However, no definitions were provided and incorporates assessment of morbidity and quality of life in considerable variation in the interpretation of questions identifying priorities. Yet, although investigations in various among individuals and across cultures is likely. developing countries reveal that women are concerned by Approximately a dozen subsequent surveys, including menstrual disorders, little attention is paid to understanding community-based, clinic-based and one national census, or ameliorating women’s menstrual complaints.1 Menstrual include some information on menstrual morbidities6–29 dysfunction, like other aspects of sexual and reproductive (Table 2). A few health surveys of special populations, health, is not included in the Global Burden of Disease such as factory workers in Vietnam17 and medical students estimates2,3 and, even as reproductive health programs in Venezuela,27,28 have also included relevant questions expand their focus to address gynaecologic morbidity, the on menstrual disorders. These surveys vary consider- utility of evaluating and treating menstrual problems is ably in the definition of and reference period for men- not generally considered.
    [Show full text]
  • Prevalence of Pelvic Floor Disorders in Various Gynecologic Cancers
    42 Buchsbaum G1, Doyle P1, Glantz J C1, Sato H1, Thomas S1 1. University of Rochester PREVALENCE OF PELVIC FLOOR DISORDERS IN VARIOUS GYNECOLOGIC CANCERS Hypothesis / aims of study The prevalence of urinary incontinence and pelvic organ prolapsed is highest in women beyond childbearing age. This is also the group that is at highest risk for gynaecologic cancer. In a recent retrospective study of patients presenting to a gynaecologic oncology office revealed a prevalence of urinary incontinence of 53.2% and of pelvic organ prolapse to or beyond the hymen of 8.7%.1 Risk factors differ for various gynaecologic cancers. Endometrial cancer is associated with unopposed estrogen exposure and obesity, ovarian cancer with nulliparity and familial factors, and cervical cancer with smoking and HPV. Pelvic floor disorders are associated with familial factors, age, parity and obesity. Based on different risk factors for different gynaecologic malignancies, it would be reasonable to assume that the prevalence of pelvic floor disorders varies between gynaecologic malignancies. Since this hypothesis has not been explored previously, we assessed the prevalence of urinary incontinence and pelvic organ prolapse stratified by type of gynaecologic malignancy: endometrial, cervical, and ovarian. We hypothesized that women with endometrial cancer will have a higher prevalence of pelvic floor disorders given both share common major risk factors. The objective of this study was to determine whether the prevalence of urinary incontinence and pelvic organ prolapse differs - in patients with different gynecological malignancies such as endometrial, ovarian, and cervical cancer and - in women with gynecologic malignancy compared to women presenting with benign gynecologic conditions.
    [Show full text]
  • Painful Sex (Dyspareunia) Labia Majora a Guide for Women Labia Minora 1
    Clitoris Painful Sex (Dyspareunia) Labia majora A Guide for Women Labia minora 1. What is dyspareunia? Perineum 2. How common is dyspareunia? 3. What causes dyspareunia? 4. How is dyspareunia diagnosed? 5. How is dyspareunia treated? These issues may start suddenly or occur gradually over a period of time and may be traced back to an event such as What is dysperunia? a previous infection. Additionally, certain disorders of the Dyspareunia, or female sexual pain, is a term used to describe urethra (the tube through which urine is emptied from the pelvic and/or vaginal pain during intercourse. The duration of bladder) can cause significant pain involving the vagina. Ex- the pain can be limited to the duration of intercourse but may last amples include urethritis (inflammation/pain in the urethra, for up to 24 hours after intercourse has finished. The duration sometimes caused by sexually transmitted diseases) and of symptoms varies widely and sometimes can be traced back urethral diverticulum (a weakness in the wall of the urethra to a specific time or event. It is often difficult to diagnose the which forms a pocket in which urine can be trapped). exact source of discomfort (muscular, vascular, foreign bodies, • Musculoskeletal issues. At times, women will describe a surgery, trauma, aging, emotional) as well as to implement the pain like being ‘stabbed in the vagina’ or chronic soreness. correct treatment options. This can be related to increased tension of the pelvic floor musculature so that it cannot properly relax. This phenom- How common is dyspareunia? enon (levator spasm) can cause constant or intermittent pain Dyspareunia is common but probably under-reported.
    [Show full text]
  • Effects of Endometriosis on Sleep Quality of Women: Does Life Style
    Youseflu et al. BMC Women's Health (2020) 20:168 https://doi.org/10.1186/s12905-020-01036-z RESEARCH ARTICLE Open Access Effects of endometriosis on sleep quality of women: does life style factor make a difference? Samaneh Youseflu1, Shahideh Jahanian Sadatmahalleh1* , Ghazall Roshanzadeh1, Azadeh Mottaghi2, Anoshirvan Kazemnejad3 and Ashraf Moini4,5,6 Abstract Background: This study aimed to compare the lifestyle factors and SQ between women with and without endometriosis. Also in this essay, the influence of food intake, socio-demographic and clinical characteristics on sleep quality of women with endometriosis was determined. Methods: Of the 156 infertile women approached for the study, 78 women had endometriosis and 78 were included in the control group. At first, each participant completed a checklist including questions about demographics, physical activity, reproductive and menstrual status. SQ was assessed by the Pittsburgh Sleep Quality Index (PSQI). Dietary data were collected using a validated 147-item semi-quantitative FFQ. Results: Irregular menstrual status, menorrhagia, dysmenorrhea, pelvic pain, history of abortion, family history of endometriosis were associated with endometriosis risk (P < 0.05). In women with physical activity more than 3 h per week, high consumption of the dairy product, and fruit endometriosis is less common (P < 0.05). The total PSQI score, and the scores for subjective sleep quality, sleep latency, sleep disturbance domains were significantly different between the two groups (P < 0.05). In women with endometriosis, poor SQ was associated with dysmenorrhea, pelvic pain, dyspareunia, physical activity, and low consumption of the dairy product, fruit, and nut (p < 0.05). Conclusion: In endometriosis women, SQ was lower than healthy individuals.
    [Show full text]